NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss
NKG2D 上调可增强肿瘤对联合抗 PD-1 和抗 VEGF 疗法的敏感性，并预防听力损失。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68865-8
Lu, Simeng; Yin, Zhenzhen; Wu, Limeng; Sun, Yao; Chen, Jie; Wu, Lai Man Natalie; Oblinger, Janet L; Blake, Day C; Xiu, Bingyu; Landegger, Lukas D; Seist, Richard; Ho, William; Jones, Adam P; Muzikansky, Alona; Stankovic, Konstantina M; Plotkin, Scott R; Chang, Long-Sheng; Xu, Lei
